LYDRAGEN Minimally Invasive Medical Products Makes Its Debut at the 4th Annual Academic Conference of the Thoracic Surgery Branch of the Anhui Provincial Society of General Practice, Jointly Exploring a New Future for the Industry

On November 8–9, 2025, the Fourth Academic Annual Conference of the Thoracic Surgery Branch of the Anhui Provincial Society of General Practice, the Second Academic Annual Conference of the Esophageal Cancer Clinical Research Special Committee of the Anhui Provincial Society of Clinical Trials, the 2025 Progress Review and Summary Meeting for Project 289, and the 2025 Bengbu City Thoracic Surgery Quality Control Training Conference will be grandly held in Bengbu.

This grand event features one plenary forum, three parallel sessions, and two hands-on training workshops, covering eight major thematic areas: lung cancer, esophageal cancer, mediastinal tumors, tracheal surgery, robotic and thoracoscopic minimally invasive techniques, perioperative ERAS, clinical trial design, and the “289” competency enhancement program. Renowned experts from China’s leading institutions have been specially invited to deliver keynote presentations, ensuring that attendees leave with clear takeaways—bringing their questions and returning with actionable solutions—across the dimensions of theory, strategy, and technology.

As an innovative company dedicated to the R&D and commercialization of minimally invasive surgical medical devices, LYDRAGEN Minimally Invasive was invited to attend this annual conference, bringing its core products and comprehensive solutions. The company set up a dedicated exhibition area on-site, providing a full-scale showcase of its technological achievements and practical experience in the field of thoracic minimally invasive surgery, which drew numerous attendees to stop by for consultations and business discussions.

Looking ahead, LYDRAGEN Minimally Invasive will continue to center on its Endsintel line of single-use electric endoscopic anastomosis devices, deepen collaboration with clinical institutions, drive ongoing technological breakthroughs to address the key challenges and pain points in thoracic surgery, and introduce minimally invasive instrument solutions that better meet clinical needs—thereby contributing to the advancement of thoracic surgical diagnosis and treatment and safeguarding patient health.